Heron Therapeutics Sets 2025 Annual Meeting Date
Ticker: HRTX · Form: 8-K · Filed: Jun 18, 2025 · CIK: 818033
Sentiment: neutral
Topics: annual-meeting, director-election, corporate-governance
Related Tickers: HRTX
TL;DR
HRTX annual meeting July 24th, vote on directors.
AI Summary
Heron Therapeutics, Inc. (HRTX) announced on June 12, 2025, that it will hold its 2025 Annual Meeting of Stockholders on July 24, 2025. The meeting will include a vote on the election of two Class II directors, Mr. Robert E. Davis and Ms. Amy T. Peterson, for a three-year term. The company's principal executive offices are located at 100 Regency Forest Drive, Suite 300, Cary, NC 27518.
Why It Matters
This filing informs shareholders about the upcoming annual meeting where key corporate decisions, including director elections, will be made, allowing them to participate in corporate governance.
Risk Assessment
Risk Level: low — This is a routine corporate filing announcing a shareholder meeting and director nominations, with no immediate financial or operational risks disclosed.
Key Players & Entities
- Heron Therapeutics, Inc. (company) — Registrant
- Robert E. Davis (person) — Nominee for Class II Director
- Amy T. Peterson (person) — Nominee for Class II Director
- July 24, 2025 (date) — Date of 2025 Annual Meeting of Stockholders
- June 12, 2025 (date) — Date of earliest event reported
- 100 Regency Forest Drive, Suite 300, Cary, NC 27518 (location) — Principal executive offices
FAQ
When is Heron Therapeutics' 2025 Annual Meeting of Stockholders?
The 2025 Annual Meeting of Stockholders is scheduled for July 24, 2025.
Who are the nominees for election as Class II directors?
The nominees for election as Class II directors are Mr. Robert E. Davis and Ms. Amy T. Peterson.
What is the term for the elected Class II directors?
The elected Class II directors will serve for a three-year term.
What is the address of Heron Therapeutics' principal executive offices?
The principal executive offices are located at 100 Regency Forest Drive, Suite 300, Cary, NC 27518.
What is the earliest event date reported in this 8-K filing?
The earliest event date reported is June 12, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 by Robert E. Davis regarding HERON THERAPEUTICS, INC. /DE/ (HRTX).